Skip to content

Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency

Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03731611
Enrollment
90
Registered
2018-11-06
Start date
2019-04-01
Completion date
2020-03-30
Last updated
2022-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Placental Insufficiency, Preterm Infant

Keywords

Umbilical cord milking

Brief summary

To investigate the effect of umbilical cord milking (UCM) on peripheral hematologic parameters including hematopoietic progenitor cells in premature infants ≤ 34 weeks gestational age with placental insufficiency. We hypothesize that UCM would enhance peripheral CD34 concentration, hemoglobin and reduce prematurity complications like NEC and IVH in preterm infant ≤ 34 week gestational age with placental insufficiency.

Detailed description

A pilot prospective randomized controlled study will be conducted among 3 groups, all of them are preterm less than 34 weeks gestational age, in the first group umbilical cord milking will be done for preterm infant with placental insufficiency. Two control groups are present, in the first one umbilical cord milking will be done for preterm infants without placental insufficiency (Insufficiency vs. no insufficiency), another group of immediate cord clamping for preterm infants with placental insufficiency will be added (milking vs. no milking), 30 cases will be recruited in each group. Umbilical cord milking (UCM) is typically performed by placing the infant below the level of the placenta. The cord is held at 20-25 cm distance from the baby and milked vigorously towards the umbilicus for 3 times at a speed of 10 cm/sec. After completion, the cord is clamped, and the neonate is handed to the resuscitation team. One milliliter of fetal blood will be taken from peripheral venous blood in the first 30 min of life and CD34 will be assessed by flow cytometry. Secondary outcomes will be documented during NICU stay that include admission CBC, peak bilirubin concentrations, CBC after 2 months, neonatal morbidity such as sepsis, bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity and polycythemia, therapeutic interventions such as need for inotropes, nasal CPAP, mechanical ventilation and phototherapy.

Interventions

PROCEDUREUmbilical Cord Milking

Umbilical cord milking (UCM) is typically performed by placing the infant below the level of the placenta. The cord is held at 20-25 cm distance from the baby and milked vigorously towards the umbilicus for 3 times at a speed of 10 cm/sec. After completion, the cord is clamped, and the neonate is handed to the resuscitation team.

Sponsors

Mansoura University Children Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
0 Minutes to No maximum
Healthy volunteers
No

Inclusion criteria

* preterm neonates \< 34 weeks gestational age

Exclusion criteria

* Vaginal bleeding due to placental abruption or tears * Multiple pregnancies * Suspected major fetal anomalies * Suspected chromosomal aberration * Maternal drug abuse * Hydrops fetalis * preterm who needed major resuscitative measures

Design outcomes

Primary

MeasureTime frameDescription
Peripheral venous CD34 at admissionfirst 24 hours of infants' lifeOne milliliter of fetal blood will be taken from peripheral venous blood in the first 30 min of life and CD34 will be assessed by flow cytometry.

Secondary

MeasureTime frameDescription
Hemoglobin at 2 months2 months after umbilical cord milkingOne milliliter of neonatal blood will be taken from peripheral venous blood at 2 months of life.
Admission plateletsfirst 24 hours of infants' lifeOne milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.
Admission WBCsfirst 24 hours of infants' lifeOne milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.
Phototherapy requirementsfirst 28 days of lifeNeed to start phototherapy for hyperbilirubinemia
Polycythemiafirst 28 days of lifearterial Hematocrit value more than 70%
Culture proven sepsisfirst 28 days of lifeSepsis confirmed by positive blood culture
Necrotizing enterocolitisfirst 28 days of lifeNecrotizing enterocolitis (Any Bell's stage)
Admission hemoglobinfirst 24 hours of infants' lifeOne milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.
Bronchopulmonary dysplasiafirst 70 days of lifeOxygen requirement at 36 weeks corrected gestational age
Need for packed RBCs transfusionfirst 28 days of lifenumber of packed RBCs transfusion
Retinopathy of prematurityfirst 28 days of lifePrethreshold and threshold diseases Retinopathy of prematurity
Need for inotropesfirst 28 days of lifeHypotension requiring inotropic support
Need for nasal CPAPfirst 28 days of liferespiratory distress requiring CPAP support
Need for mechanical ventilationfirst 28 days of liferespiratory distress requiring mechanical ventilation support
Duration of oxygen therapyfirst 70 days of lifeDuration of oxygen therapy
Intraventricular hemorrhagefirst 28 days of lifeIntraventricular hemorrhage of all grades

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026